Sporadic inclusion body myositis (sIBM) presents with a characteristic ... pathways might prove helpful in arresting disease progression. sIBM is often misdiagnosed as polymyositis or other ...

US biotech Abcuro has reeled in $200 million in third-round financing that should allow it to complete its pivotal trial of ...

Abcuro Inc. has raised a $200 million Series C financing to fund late-stage development and support commercial launch ...

Inclusion Body Myositis- Features asymmetric muscle weakness and distinct histopathologic findings, such as rimmed vacuoles. Drug-induced Myopathies- Commonly associated with medications like ...

New research examining the skeletal muscle cells of patients with inclusion body myositis (IBM) has revealed that the nucleic acid-binding protein TDP-43, which is normally restricted to the ...

Exposures to silica dust, solvents or heavy metals increase the likelihood of developing various forms of myositis, ...

Myopathic (myo = muscle, pathy = disease) conditions can include polymyositis, dermatomyositis, inclusion body myositis, and various myopathies ... including the heart. The rate of progression of the ...

The Boston-area company’s previous raises were also aimed at getting its investigational antibody treatment for inclusion ...

The funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.